APA (7th ed.) Citation

D, T., A, W., E, G., & H, S. (2017). Efficacy, safety and tolerability of the CCR1 antagonist BAY 86-5047 for the treatment of endometriosis-associated pelvic pain: A randomized controlled trial. Acta obstetricia et gynecologica Scandinavica, 96(6), 694. https://doi.org/10.1111/aogs.13105

Chicago Style (17th ed.) Citation

D, Trummer, Walzer A, Groettrup-Wolfers E, and Schmitz H. "Efficacy, Safety and Tolerability of the CCR1 Antagonist BAY 86-5047 for the Treatment of Endometriosis-associated Pelvic Pain: A Randomized Controlled Trial." Acta Obstetricia Et Gynecologica Scandinavica 96, no. 6 (2017): 694. https://doi.org/10.1111/aogs.13105.

MLA (9th ed.) Citation

D, Trummer, et al. "Efficacy, Safety and Tolerability of the CCR1 Antagonist BAY 86-5047 for the Treatment of Endometriosis-associated Pelvic Pain: A Randomized Controlled Trial." Acta Obstetricia Et Gynecologica Scandinavica, vol. 96, no. 6, 2017, p. 694, https://doi.org/10.1111/aogs.13105.